H.E.S.S. observations of the shell-type SNR RX J1713.7 - 3946

por Berge, D
Publicado 2005

The SNR RX J1713.7 - 3946: Comparison of keV to TeV data and modelling of the broadband energy spectrum

por Berge, D
Publicado 2005

Background Modelling in Very-High-Energy gamma-ray Astronomy

por Berge, D, Funk, S, Hinton, J
Publicado 2006

Morphological and spectral studies of the shell-type SNRs RX J1713.7-3946 and RX J0852.0-4622 with H.E.S.S

por Berge, D, Funk, S, Lemoine-Goumard, M
Publicado 2007

18th International Symposium on Very High Energy Cosmic Ray Interactions

por Berge, D, De Roeck, A, Mangano, M, Pattison, B
Publicado 2015

Association between lymphocytes, hippocampus volume and depressive symptoms in drug – naïve First Episode Psychosis

por Toll, A., Bergé, D., El-Abidi, K., Legido, T., Pérez-Solà, V., Mané, A.
Publicado 2022

Radiosensitization of hypoxic tumour cells by S-nitroso-N-acetylpenicillamine implicates a bioreductive mechanism of nitric oxide generation

por Janssens, M Y, Verovski, V N, Van den Berge, D L, Monsaert, C, Storme, G A
Publicado 1999

The Octant Module of the ATLAS Level-1 Muon to Central Trigger Processor Interface

por Haas, Stefan, Ask, S, Berge, D, Ellis, Nick, Farthouat, P, Krasznahorkay, A, Pauly, T, Schuler, G, Spiwoks, R, Wengler, T
Publicado 2007

Framework for Testing and Operation of the ATLAS Level-1 MUCTPI and CTP

por Spiwoks, R, Berge, D, Ellis, N, Farthouat, P, Haas, S, Lundberg, J, Maettig, S, Messina, A, Pauly, T, Sherman, D
Publicado 2009

Intrinsic radiosensitivity of human pancreatic tumour cells and the radiosensitising potency of the nitric oxide donor sodium nitroprusside.

por Verovski, V. N., Van den Berge, D. L., Soete, G. A., Bols, B. L., Storme, G. A.
Publicado 1996

Commissioning of the ATLAS Level-1 Central Trigger

por Pauly, T, Ask, S, Berge, D, Ellis, Nick, Farthouat, P, Gällnö, P, Haas, S, Krasznahorkay, A, Schuler, G, Spiwoks, R, Wengler, T
Publicado 2006

Correlation between BDNF levels and folic acid levels at baseline in drug-naïve First Episode Psychosis

por Toll, A., Bergé, D., Canosa, I., Martín - Subero, M., Legido, T., Fernandez - Hinchado, C., Perez - Sola, V., Mané, A.
Publicado 2023

NF-κB inhibition impairs the radioresponse of hypoxic EMT-6 tumour cells through downregulation of inducible nitric oxide synthase

por Ridder, M De, Van den Berge, D L, Verovski, V N, Monsaert, C, Wauters, N, Storme, G A
Publicado 2003

The ATLAS Level-1 Muon to Central Trigger Processor Interface

por Berge, D, Ellis, Nick, Farthouat, P, Haas, S, Klofver, P, Krasznahorkay, A, Messina, A, Pauly, T, Schuler, G, Spiwoks, R, Wengler, T
Publicado 2007

Hardware studies for the upgrade of the ATLAS Central Trigger Processor

por Berge, D, Burdalo, J, Ellis, N, Farthouat, P, Haas, S, Lundberg, J, Maettig, S, Messina, A, Pauly, T, Sherman, D, Spiwoks, R
Publicado 2009

Chronic hypoxia modulates tumour cell radioresponse through cytokine-inducible nitric oxide synthase

por Berge, D L Van den, Ridder, M De, Verovski, V N, Janssens, M Y, Monsaert, C, Storme, G A
Publicado 2001

Commissioning of the ATLAS Level-1 Central Trigger

por Berge, D, Ehrenfeld, W, Ellis, Nick, Farthouat, P, Fischer, G, Haas, S, Haller, J, Maettig, S, Messina, A, Pauly, T, Sherman, D, Spiwoks, R
Publicado 2008

Commissioning of the ATLAS Level-1 Central Trigger

por Berge, D, Ehrenfeld, W, Ellis, N, Farthouat, P, Fischer, G, Haas, S, Haller, J, Maettig, S, Messina, A, Pauly, T, Sherman, D, Spiwoks, R
Publicado 2010

Low-level doxorubicin resistance in P-glycoprotein-negative human pancreatic tumour PSN1/ADR cells implicates a brefeldin A-sensitive mechanism of drug extrusion.

por Verovski, V. N., Van den Berge, D. L., Delvaeye, M. M., Scheper, R. J., De Neve, W. J., Storme, G. A.
Publicado 1996

Distinctive features of First Episode of Psychosis during the Covid-19 pandemic

por Casanovas, F., Dinamarca, F., Pérez Oms, A., Llimona Sánchez, C., García Hernández, D., Ginés, J.M., Pérez-Solà, V., Bergé, D., Mané, A.
Publicado 2022